SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-016870
Filing Date
2019-11-12
Accepted
2019-11-12 13:49:55
Documents
46
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 729779
2 ex31-1.htm EX-31.1 17372
3 ex31-2.htm EX-31.2 17449
4 ex32.htm EX-32 7383
  Complete submission text file 0001493152-19-016870.txt   2475199

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pvct-20190930.xml EX-101.INS 338932
6 XBRL SCHEMA FILE pvct-20190930.xsd EX-101.SCH 30357
7 XBRL CALCULATION FILE pvct-20190930_cal.xml EX-101.CAL 37497
8 XBRL DEFINITION FILE pvct-20190930_def.xml EX-101.DEF 95566
9 XBRL LABEL FILE pvct-20190930_lab.xml EX-101.LAB 198303
10 XBRL PRESENTATION FILE pvct-20190930_pre.xml EX-101.PRE 148385
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 191208327
SIC: 2834 Pharmaceutical Preparations